西点药业：拟2500万元至5000万元回购公司股份

Group 1 - The core point of the article is that West Point Pharmaceutical (301130) announced a share buyback plan, intending to repurchase shares worth between 25 million to 50 million yuan, with a maximum buyback price set at 42 yuan per share [1] Group 2 - The company aims to enhance shareholder value through this buyback initiative [1] - The buyback range indicates a strategic move to stabilize or increase the stock price amid market fluctuations [1] - The announcement reflects the company's confidence in its financial health and future prospects [1]